[HTML][HTML] N6-methyladenosine (m6A) in cancer stem cell: From molecular mechanisms to therapeutic implications

L Wang, Y Tang - Biomedicine & Pharmacotherapy, 2023 - Elsevier
The emergence of drug resistance and metastasis has long been a difficult problem for
cancer treatment. Recent studies have shown that cancer stem cell populations are key …

Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities

N Yin, X Li, X Zhang, S Xue, Y Cao… - … and Targeted Therapy, 2024 - nature.com
Immunotherapy represented by anti-PD-(L) 1 and anti-CTLA-4 inhibitors has revolutionized
cancer treatment, but challenges related to resistance and toxicity still remain. Due to the …

[HTML][HTML] METTL14 regulates microglia/macrophage polarization and NLRP3 inflammasome activation after ischemic stroke by the KAT3B-STING axis

Y Li, J Li, Q Yu, L Ji, B Peng - Neurobiology of Disease, 2023 - Elsevier
Abstract N6-methyladenosine (m6A) plays a crucial role in ischemic stroke, whereas the role
of methyltransferase-like 14 (METTL14) in ischemic stroke remains unknown. A model of …

System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma

R Huang, L Guo, C Chen, Y Xiang, G Li, J Zheng… - PloS One, 2023 - journals.plos.org
Ubiquitin Conjugating Enzyme 2C (UBE2C) is an emerging target gene for tumor
progression. However, the tumorigenic effect and mechanism of UBE2C in adrenocortical …

CYFIP2 serves as a prognostic biomarker and correlates with tumor immune microenvironment in human cancers

Q Peng, B Ren, K Xin, W Liu, MS Alam, Y Yang… - European Journal of …, 2023 - Springer
Background The mechanisms whereby CYFIP2 acts in tumor development and drives
immune infiltration have been poorly explored. Thus, this study aimed to identifying the role …

Hypoxia-induced ALKBH5 aggravates synovial aggression and inflammation in rheumatoid arthritis by regulating the m6A modification of CH25H

D Fan, Q Geng, B Wang, X Wang, Y Xia, L Yang… - Clinical …, 2024 - Elsevier
Previous studies have shown that epigenetic factors are involved in the occurrence and
development of rheumatoid arthritis (RA). However, the role of N 6-methyladenosine (m 6 A) …

METTL3-mediated N6-methyladenosine modification of STAT5A promotes gastric cancer progression by regulating KLF4

Y Zang, Z Tian, D Wang, Y Li, W Zhang, C Ma, Z Liao… - Oncogene, 2024 - nature.com
Abstract N6-methyladenosine (m6A) is the predominant post-transcriptional RNA
modification in eukaryotes and plays a pivotal regulatory role in various aspects of RNA fate …

Significance of N6-methyladenosine RNA methylation regulators in diagnosis and subtype classification of primary Sjögren's syndrome

J Li, K Xie, M Xu, Y Wang, Y Huang, T Tan, H Xie - Heliyon, 2024 - cell.com
The importance of N6-methyladenine (m6A) in mRNA metabolism, physiology, pathology
and other life processes is well recognized. However, the exact role of m6A regulators in …

METTL3 Regulates the m6A Modification of NEK7 to Inhibit the Formation of Osteoarthritis

X Xiong, H Xiong, J Peng, Y Liu, Y Zong - Cartilage, 2023 - journals.sagepub.com
Objective Osteoarthritis (OA) is a common degenerative joint disease. The occurrence of OA
slowly destroys the soft tissue structure of the patient's joint. Severe cases could lead to …

The role of RNA methylation in tumor immunity and its potential in immunotherapy

Y Li, H Jin, Q Li, L Shi, Y Mao, L Zhao - Molecular Cancer, 2024 - Springer
RNA methylation, a prevalent post-transcriptional modification, has garnered considerable
attention in research circles. It exerts regulatory control over diverse biological functions by …